We are pleased to announce that on 15 September 2023, the GMP inspection by Swissmedic took place at our production facility in Glattfelden. The inspection was carried out by the Therapeutic Products Control of the Canton of Zurich.

We are very satisfied with the outcome and very confident to complete the inspection process in a timely manner.

The Good Manufacturing Practice (GMP) certification according to pharmaceutical standards will enable swisscann to produce so-called Active Pharmaceutical Ingredients (APIs) from cannabis raw material.

swisscann team